IL37 and psoriasis: These treatments function by specifically focusing on important cytokines or proteins on the surface of cells that are involved in the development of psoriasis, such as tumor necrosis factor-alpha (TNF-α), interleukin-17 (IL-17), and interleukin-23 (IL-23).